Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

154
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
154
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

316
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
316
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

616
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
616
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

303
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
303
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

417
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
417
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

590
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
590

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vykat XR (diazoxide choline-extended release): a new FDA-approved treatment for hyperphagia in Prader-Willi syndrome.

Annals of medicine and surgery (2012)·2026
Same author

SHAPING MINDS: A systematic review and meta-analysis on the effects of structured exercise in schizophrenia spectrum disorders.

Psychiatry research·2025
Same author

A critical review of health and financial implications of obesity during the COVID-19 pandemic.

Annals of medicine and surgery (2012)·2024
Same author

Improving allergy management and treatment: a proposed algorithm and curriculum for prescribing allergen immunotherapy in the primary care setting.

NPJ primary care respiratory medicine·2024
Same author

Safety and Efficacy of Ultrasound-Guided Cryoablation for Benign Breast Fibroepithelial Lesions.

Journal of breast imaging·2024
Same author

Abbreviated Screening Breast MRI in Women at Higher-than-Average Risk for Breast Cancer with Prior Normal Full Protocol MRI.

Journal of breast imaging·2024

Related Experiment Video

Updated: Nov 18, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.2K

Suicidal Behavior and Medication Adherence in Schizophrenic Patients.

Zain I Warriach1, Marcos A Sanchez-Gonzalez1, Gerardo F Ferrer1

  • 1Department of Psychiatry, Larkin Community Hospital, Miami, USA.

Cureus
|February 8, 2021
PubMed
Summary

Improving antipsychotic medication adherence in schizophrenia patients, particularly with second-generation antipsychotics (SGA) and long-acting injectables (LAIs), can reduce suicidal behavior and mortality. Integrated treatment for co-occurring conditions is also vital.

Keywords:
medication adherence strategiesschizophreniasuicide

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.8K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.1K

Related Experiment Videos

Last Updated: Nov 18, 2025

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
05:52

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

15.2K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.8K
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

4.1K

Area of Science:

  • Psychiatry
  • Clinical Pharmacology
  • Public Health

Background:

  • Suicide and hospitalizations are significant complications in schizophrenia.
  • Antipsychotic medication non-adherence is a major challenge in managing schizophrenia.
  • Effective treatment strategies are crucial for improving outcomes in schizophrenia patients.

Purpose of the Study:

  • To review the impact of antipsychotic medication compliance on suicidal behavior and hospitalizations in schizophrenia.
  • To explore the role of specific antipsychotics, like clozapine and long-acting injectables (LAIs), in reducing mortality.
  • To discuss interventions for improving medication adherence and managing comorbid conditions.

Main Methods:

  • Literature review of studies on schizophrenia, suicide, antipsychotic adherence, and treatment outcomes.
  • Analysis of data linking second-generation antipsychotics (SGA) and LAIs to reduced suicidal behavior and mortality.
  • Examination of evidence for comorbid condition treatment and physician intervention strategies.

Main Results:

  • Medication adherence with SGAs (e.g., clozapine) and LAIs (e.g., paliperidone) is associated with decreased suicidal behavior and all-cause mortality.
  • Concurrent treatment of depression and substance abuse disorder reduces mortality and hospitalizations.
  • Long-term benzodiazepine use correlates with increased mortality in schizophrenia patients.

Conclusions:

  • Optimizing antipsychotic medication adherence is critical for reducing suicide risk and improving survival in schizophrenia.
  • Integrated care addressing comorbid conditions and utilizing effective physician interventions enhances patient outcomes.
  • Strategies like motivational interviewing and cognitive behavior therapy can improve adherence and mitigate risks.